Evidence map›Paper›PMID 42315936›Full record

ArticleThe European journal of neuroscience2026

Sex-Dependent Effects of CSF1R-Mediated Myeloid Cell Depletion in a Mouse Model of Multiple System Atrophy.

Kristina Battis, Michael Mante, Isabel Naumann, Marie Andert, Ha Yeon Kim, Wei Xiang, Robert A Rissman, Jürgen Winkler, Alana Hoffmann

Abstract read
In one paragraph

Article in The European journal of neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kristina BattisDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Michael ManteDepartment of Physiology and Neuroscience, Keck School of Medicine of the University of Southern California, San Diego, California, USA.
Isabel NaumannBiotech Research and Innovation Center, University of Copenhagen, Copenhagen, Denmark.
Marie AndertDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Ha Yeon KimDepartment of Physiology and Neuroscience, Keck School of Medicine of the University of Southern California, San Diego, California, USA.
Wei XiangDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Robert A RissmanDepartment of Physiology and Neuroscience, Keck School of Medicine of the University of Southern California, San Diego, California, USA.
Jürgen WinklerDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0003-0630-9204
Alana HoffmannDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0002-5476-1038

Funding

BaCaTeC (Bavaria California Technology Center)Deutsche Forschungsgemeinschaft 270949263/GRK2162Deutsche Forschungsgemeinschaft 498972649Deutsche Forschungsgemeinschaft 505539112Erstantragssteller-programm of the IZKFMultiple System Atrophy Coalition
6 · The paper itself

Abstract

Sex-dependent differences in neurodegenerative disorders are becoming increasingly relevant in diagnosis and development of therapeutic targets. Although multiple system atrophy (MSA), a devastating and rapidly progressing atypical parkinsonian disorder, is distributed equally among sexes, sex-specific differences have been reported regarding autonomic dysfunctions, severity of motor symptoms, and survival rate, suggesting a need for sex-specific treatment approaches. Neuroinflammation is a prominent hallmark in MSA pathology. Distinct activation patterns and increased phagocytosis of central nervous system (CNS) myeloid cells were observed, indicating a damaging role in this disease. In our previous study, we showed that colony-stimulating factor 1 receptor (CSF1R)-mediated depletion of myeloid cells in a mouse model of MSA led to a two-faced outcome, comprised of a prolonged survival and delayed onset of neurological dystonia-like symptoms, but also an aggravated motor phenotype and loss of dopaminergic neurons. Here, we re-analyzed our previous findings to study sex-specific effects in MSA in the presence and absence of CNS myeloid cells. Intriguingly, myeloid cell depletion was initially more effective in male animals. Although no sex-specific effects were detected in motor behavior, the occurrence of dystonia-like neurological symptoms was reduced, and neuronal loss was alleviated in male animals. Together, our findings provide insight into sex-specific differences of CSF1R-mediated myeloid cell depletion in MSA, emphasizing the need to study sex-specific treatment strategies in neurodegenerative disorders.

Indexed as

Multiple System AtrophyMyeloid CellsReceptors, Granulocyte-Macrophage Colony-Stimulating FactorSex CharacteristicsAnimalsDisease Models, AnimalFemaleMaleMiceMice, Inbred C57BLCsf1r protein, mouseReceptors, Granulocyte-Macrophage Colony-Stimulating Factorcolony‐stimulating factor 1 receptormultiple system atrophymyeloid cellssex differences

Identifiers

PMID42315936
PMCPMC13279752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.